Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Ipilimumab (Yervoy) 50mg/10ml Sdv [Thay] (CDM 24089610) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 12, 2026 , from http://ppman.hank.ai/transparency/procedure/24089610/by-state?code_type=CDM
“Ipilimumab (Yervoy) 50mg/10ml Sdv [Thay] (CDM 24089610) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/24089610/by-state?code_type=CDM. Accessed
November 12, 2026 .
“Ipilimumab (Yervoy) 50mg/10ml Sdv [Thay] (CDM 24089610) by State,” HANK Price Transparency ,
accessed November 12, 2026 ,
http://ppman.hank.ai/transparency/procedure/24089610/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
24089610 — Ipilimumab (Yervoy) 50mg/10ml Sdv [Thay]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$13,692
National median
$12,203 – $14,082
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 24089610 (CDM), with interquartile range
State Median p25 p75
NE $13,692 $12,203 $14,082